Looking Back at 2022: Top 5 Stories About Cancer Research and Cancer Care
My picks for five of the top cancer research stories of 2022.
Exploring progress in cancer research from the patient perspective
My picks for five of the top cancer research stories of 2022.
A look at six highly rated national charities that engage primarily in cancer research.
A blood test that can detect cancer before any symptoms appear, and save lives as a result, is sometimes referred to as the “holy grail” of cancer research. Are we there yet?
Dealing with a cancer diagnosis can become much more manageable when we’re not afraid to reach out for support.
Top cancer research stories for early summer 2014 include new uses for existing cancer drugs and a major study on breast cancer risk and environmental toxins.
The newer cancer medications are often extremely highly priced, and covering the costs of care is an increasing problem for cancer patients.
As a result of the experiences I’ve had in life so far, which unfortunately have included two episodes with cancer, there were a number of very important life lessons that I probably learned sooner than I otherwise would have.
Advocates met with representatives in Congress to ask for their support on important initiatives in the fight against breast cancer.
Top cancer research stories for Spring 2014 include new guidelines on survivorship care and clinical trial findings for an experimental drug to treat hormone receptor-positive breast cancer.
A major study on breast cancer screening was published recently in the journal of the American Medical Association.
In “adaptive” clinical trial design, the goal is to identify as rapidly as possible new drug therapies that show a likelihood of being successful in specific patient populations.
Top cancer research stories for Winter 2014 include studies on mammography, risk reduction for carriers of BRCA gene mutations and radiation therapy for early stage breast cancer.
Attendees at the recent San Antonio Breast Cancer Symposium heard from a researcher who has spent thirty years studying issues related to the measurement of quality of life for cancer patients and how it can be improved.